• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Johnson & Johnson Is in the News, but How Do the Charts Look?

I am not focused on today's price movement of the stock but the pattern from the end of 2017.
By BRUCE KAMICH
Aug 27, 2019 | 08:25 AM EDT
Stocks quotes in this article: JNJ

Johnson & Johnson ( JNJ) is the Real Money Stock of the Day on the heels of the Oklahoma opioid ruling. Its is also an Action Alerts PLUS holding.
 
A judge in Oklahoma on Monday ruled that JNJ had intentionally played down the dangers and oversold the benefits of opioids, and ordered it to pay the state $572 million in the first trial of a drug manufacturer over the prescription painkillers. The company said it would appeal what it called a "flawed" decision.

The amount fell short of the $17 billion judgment that Oklahoma had sought from the JNJ.

What should investors do now with the judgement coming in less than expected but with more opioid cases as well as talc litigation out there? My humble suggestion is to look at the longer-term picture on the charts.
 
In the daily bar chart of JNJ, below, we can see that the price of the stock is pretty close to where it started the calendar year, leaving investors with a return shy of 3%. Prices did rally from the late December low to a high at the end of June but those gains were given back the past two months. JNJ is trading below the declining 50-day moving average line and the declining 200-day line. The 50-day average is below the 200-day indicator for a dead or death cross.
 
The On-Balance-Volume (OBV) line followed the price action up and down. The Moving Average Convergence Divergence (MACD) oscillator is below the zero line in a bearish configuration.
 
 
In the weekly bar chart of JNJ, below, we see a different and more bearish picture. Since late 2017 we have seen three big attempts for the stock price to move higher -- a possible triple-top formation. Two rallies that stopped short of the $150 level and a more recent rally in May that stopped at $145. In a classic top pattern you want to see volume diminish through the pattern but I don't see that. However, that pattern is revealed in the OBV line.
 
The MACD oscillator also shows a weakening pattern with lower peaks, which is a sign that the trend strength is diminishing. Right now it does not matter whether the neckline is upward sloping or horizontal.
 
 
In this first Point and Figure chart of JNJ using percentage changes, below, we can see an upside price target of $143. This sounds like a positive spin but the target is not a new high for the move up. A trade at $146.49 would be positive and a decline to $126.18 would be bearish.
 

In this second Point and Figure chart, below, we used the average true range to plot the X's and O's and here a downside price target of $110 is shown. It all depends how you torture the data.

 
Bottom-line strategy: Bullish traders may be saying or thinking that this is not the first rodeo for JNJ in the courts. They are a big and diversified company with insurance and skilled lawyers. That is true but the mood of the markets can change and that gets reflected in the charts. I am not focused on today's price movement of the stock but the pattern from the end of 2017.
 
I think there are other solid companies out there that pay a 3% dividend yield with stronger looking charts.
 

Johnson & Johnson is a holding in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio. Want to be alerted before Cramer buys or sells JNJ? Learn more now.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

Action Alerts PLUS, which Cramer manages as a charitable trust, is long JNJ.

TAGS: Litigation | Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Healthcare | Pharmaceuticals | Stock of the Day

More from Stocks

Lopsided Market Returns

James "Rev Shark" DePorre
Jun 5, 2023 4:22 PM EDT

Despite the intraday reversal in Apple, Microsoft, Alphabet, Amazon, and Tesla, all helped the Nasdaq 100 outperform the other indexes as the small caps disappointed.

How to Trade MongoDB After Its Huge Upside Move

Bruce Kamich
Jun 5, 2023 1:45 PM EDT

Let's check out the charts and indicators for clues.

This Value Portfolio of Lovable Losers Is Down But Not Out

Jonathan Heller
Jun 5, 2023 1:10 PM EDT

With about six months to go, anything can happen for the 2023 Tax Loss Selling Recovery Portfolio.

Friday's Cheer Turns to Monday Drear

James "Rev Shark" DePorre
Jun 5, 2023 11:35 AM EDT

Even the bulls will likely agree that this market needs better participation and breadth.

As Palo Alto Networks Joins the S&P 500, Here's How to Play the Stock

Stephen Guilfoyle
Jun 5, 2023 11:24 AM EDT

This 'best-in-class' cybersecurity name was already hot, before the news.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:19 PM EDT CHRIS VERSACE

    AAP Podcast: This Company Is Not Going 'Solo'

    Listen in as I talk with the very diversified Solo...
  • 01:51 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Adjusting Your Trading Approach to Shifting Market...
  • 06:54 PM EDT CHRIS VERSACE

    AAP Podcast: A Tongue -- and a Market -- Twister: 'Get a Debt Deal Done'

    Listen in as the Action Alerts PLUS Podcast tackle...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login